Our data showed that ligation of CD86 with CTLA4Ig in vitro could significantly enhance the tumor-killing ability of NK-92MI cells to K562 tumor cells (Figure 4C), which suggested that CD86 on NK cells might be involved in the process of regulating NK cell function. Here, CD86 is linked to neoplasm.